Fig. 1From: Clinical experience with the AKT1 inhibitor miransertib in two children with PIK3CA-related overgrowth syndromeMRI at 2 weeks of age showing right hemimegalencephaly and polymicrogyria of the parietal lobe (patient two)Back to article page